Understand the source comparison
PE 22 28: Neurogenesis vs Neuroprotection Comparison
PE occupies a unique position in the peptide research landscape because it demonstrates both neurogenic and neuroprotective properties through the same mechanism. Understanding the distinction—and overlap—between these two effects is critical for experim
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- PE 22 28 occupies a unique position in the peptide research landscape because it demonstrates both neurogenic and neuroprotective properties through the same mechanism. Understanding the distinction—and overlap—between these two effects is critical for experimental design.
- Primary Pathway
- BDNF upregulation → neural progenitor proliferation in dentate gyrus
- TREK-1 antagonism → reduced neuronal hyperpolarization under stress
- TREK-1 blockade increases baseline excitability and BDNF expression simultaneously
- Timeline
- 7–14 days for measurable doublecortin+ cell increases
- Immediate (within hours of administration) for excitability changes
- Neuroprotection is acute; neurogenesis is subacute
- Biomarker
- Doublecortin, Ki67, DCX immunostaining
- Reduced caspase-3 activation, preserved MAP2 staining
- Both present in preclinical models at 0.5–1.0 mg/kg
- Clinical Relevance
- Depression, cognitive decline, memory impairment
- Stroke, traumatic brain injury, neurodegenerative disease
- TREK-1 implicated in both mood disorders and ischemic brain injury
- Comparable Peptides
- Dihexa (HGF pathway), P21 (CNTF analog)
- Cerebrolysin (neurotrophic cocktail), SS-31 (mitochondrial protection)
- No direct comparator—mechanism is unique among research peptides
- The practical implication: PE 22 28 can be used in research models investigating either acute neuroprotection (ischemia, excitotoxicity) or chronic neuroplasticity (learning, mood, age-related cognitive decline). Most peptides excel at one or the other—PE 22 28's dual activity reflects the fact that TREK-1 channels regulate both baseline neuronal function and stress-induced neuronal survival.